Yuanqi Biopharmaceutical
元启制药
Yuanqi Biopharmaceutical
Biotech/Healthcare
Yuanqi Pharma conducts exploratory research on challenging targets, including GPCRs, by combining a deep understanding of biology and multiple research strategies with emerging technologies such as target structure research and artificial intelligence.
Latest round: Series A (2022)
Source: ChinaBulls — chinabulls.com
Last updated 2022-06-01
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.